The protections of GINA play a key role in the decision of many of my healthy patients to decide to undergo genetic testing. My criticism is that GINA is unfair to people who might suffer discrimination in health. insurance for non-genetic reasons.

The Joint Commission, which accredits our nation's hospitals, eliminated the sole element of performance that governed clinical ethics services. This decision impedes equity and undercuts progress toward fostering ethical practice in health care.

This transcript was generated by computer and may contain errors. Aashna Lal, The Hastings Center Thank you all for joining us today. Welcome to anti-black racism, health and health care....

“Bioethics” has been defined in several different ways. Most broadly, it is the interdisciplinary study of ethical, legal, and social issues arising in the life sciences and health care. Though...

Monday, February 26 and Tuesday, February 27, 2018 For the last quarter century, researchers have been asking whether genomic information might have negative psychosocial effects. Anxiety, depression, disrupted relationships, and heightened...

Research oversight bodies conducting for-cause investigations often fail to interview research subjects who have complaints of mistreatment. I argue that this failure is a mistake for three reasons. First, because...

Growing concern over financial interests in clinical research has provoked greater efforts to identify effective management strategies.1 Among the strategies discussed is the disclosure of financial interests to potential research...

A dwarf walks into a bar. I was searching for a funny anecdote that would begin with that sentence when I ran into Danny Black, a dwarf who has walked...